Stage I sarcoidosis with bilateral hilar lymphadenopathy and no infection or malignancy, what is the recommended management?

Stage I sarcoidosis with bilateral hilar lymphadenopathy and no infection or malignancy, what is the recommended management?

• A. Invasive tissue biopsy is required to confirm the stage
• B. Immediate immunosuppressive therapy
• C. Observation with monitoring; no treatment
• D. Radiation therapy

Answer: (C)

In Stage I sarcoidosis, where chest imaging shows bilateral hilar lymphadenopathy without parenchymal involvement or infection/malignancy, the prognosis is usually favorable and many cases resolve on their own. Because there are no organ-threatening findings or significant symptoms here, there is no need for active therapy. The best approach is observation with regular follow-up to monitor for progression or the development of symptoms, along with baseline assessments such as pulmonary function tests and appropriate evaluations for potential extrapulmonary involvement. Immunosuppressive therapy is reserved for symptomatic disease or organ dysfunction, which isn’t present in this scenario, and invasive biopsy or radiation therapy isn’t routinely required given the classic presentation. If diagnostic uncertainty arises or alternative causes must be excluded, biopsy may be reconsidered, but not as a routine step in a straightforward Stage I case.

In Stage I sarcoidosis, where chest imaging shows bilateral hilar lymphadenopathy without parenchymal involvement or infection/malignancy, the prognosis is usually favorable and many cases resolve on their own. Because there are no organ-threatening findings or significant symptoms here, there is no need for active therapy. The best approach is observation with regular follow-up to monitor for progression or the development of symptoms, along with baseline assessments such as pulmonary function tests and appropriate evaluations for potential extrapulmonary involvement. Immunosuppressive therapy is reserved for symptomatic disease or organ dysfunction, which isn’t present in this scenario, and invasive biopsy or radiation therapy isn’t routinely required given the classic presentation. If diagnostic uncertainty arises or alternative causes must be excluded, biopsy may be reconsidered, but not as a routine step in a straightforward Stage I case.